In a pivotal interview, the Prime Minister condemns past Conservative-led administrations for "breaking" the NHS and anticipates a damning report on the state of children’s health service
Nice’s decision to deny NHS coverage for Lecanemab contrasts with MHRA’s approval, citing high costs and minimal benefits compared to risks of serious side-effects
Voxelotor, a promising new drug for sickle cell disease, will be made available to patients in england, aiming to reduce hospital visits and improve life quality.